DOP006 A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
Meserve, J, Aniwan, S, Koliani-Pace, J L, Shashi, P, Weiss, A, Faleck, D, Winters, A, Chablaney, S, Kochhar, G, Boland, B, Singh, S, Hirten, R, Shmidt, E, Bohm, M, Sagi, S V, Fischer, M, Lukin, D, HudVolume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.043
Date:
January, 2018
File:
PDF, 227 KB
english, 2018